Attorneys general from 43 states and the District of Columbia have announced a significant $700 million settlement with Johnson & Johnson. The litigation addresses allegations that the pharmaceutical giant knowingly withheld information about the carcinogenic properties of its talcum-based body powder products, such as Baby Powder and Shower to Shower. These lawsuits, filed Tuesday, claim Johnson & Johnson had awareness of the potential risks dating back to the 1950s, specifically concerning the presence of asbestos in talcum powder, which has been linked to serious medical conditions including mesothelioma, cancer, fibrosis, and lung disease.
The settlement also includes a prohibition against Johnson & Johnson manufacturing, selling, or distributing these talcum-based products in the United States. The company has sold over 600 million talc products globally since 1992, making this agreement a substantial development in ongoing product liability and consumer safety litigation. More details are available in the original article.